Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Stomach Neoplasms × Ado-Trastuzumab Emtansine × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Stomach Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1

Interventions

Gastrectomy 12 Gastroscopy 11 Observation 9 Drug Therapy 8 Surveys and Questionnaires 7 Endoscopic Mucosal Resection 7 Surgical Procedures, Operative 6 Immune Checkpoint Inhibitors 6 Paclitaxel 5 Blood Specimen Collection 5 Tomography, X-Ray Computed 4 Oxaliplatin 4 Irinotecan 4 Hyperthermic Intraperitoneal Chemotherapy 4 Cisplatin 4 tislelizumab 3 Trastuzumab 3 Robotic Surgical Procedures 3 Ramucirumab 3 Radiotherapy 3 Positron Emission Tomography Computed Tomography 3 Nivolumab 3 Neoadjuvant Therapy 3 Laparoscopy 3 Immunotherapy 3 Capecitabine 3 Biopsy 3 taxane 2 Watchful Waiting 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07389876 2026-02-05

G/GEJ

Fudan University

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡